Your browser doesn't support javascript.
loading
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Agathangelidis, Andreas; Chatzidimitriou, Anastasia; Gemenetzi, Katerina; Giudicelli, Veronique; Karypidou, Maria; Plevova, Karla; Davis, Zadie; Yan, Xiao-Jie; Jeromin, Sabine; Schneider, Christof; Pedersen, Lone Bredo; Tschumper, Renee C; Sutton, Lesley-Ann; Baliakas, Panagiotis; Scarfò, Lydia; van Gastel, Ellen J; Armand, Marine; Tausch, Eugen; Biderman, Bella; Baer, Constance; Bagnara, Davide; Navarro, Alba; Langlois de Septenville, Anne; Guido, Valentina; Mitterbauer-Hohendanner, Gerlinde; Dimovski, Aleksandar; Brieghel, Christian; Lawless, Sarah; Meggendorfer, Manja; Brazdilova, Kamila; Ritgen, Matthias; Facco, Monica; Tresoldi, Cristina; Visentin, Andrea; Patriarca, Andrea; Catherwood, Mark; Bonello, Lisa; Sudarikov, Andrey; Vanura, Katrina; Roumelioti, Maria; Skuhrova Francova, Hana; Moysiadis, Theodoros; Veronese, Silvio; Giannopoulos, Krzysztof; Mansouri, Larry; Karan-Djurasevic, Teodora; Sandaltzopoulos, Raphael; Bödör, Csaba; Fais, Franco; Kater, Arnon P.
Afiliação
  • Agathangelidis A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Chatzidimitriou A; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Gemenetzi K; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
  • Giudicelli V; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Karypidou M; Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
  • Plevova K; International ImMunoGeneTics Information System (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (IGH), Unité Mixte de Recherche (UMR), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier, Montpellier, France.
  • Davis Z; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Yan XJ; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic.
  • Jeromin S; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Schneider C; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
  • Pedersen LB; The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY.
  • Tschumper RC; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Sutton LA; University Hospital Medical Center, Ulm, Germany.
  • Baliakas P; Deparment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Scarfò L; Department of Immunology, Mayo Clinic, Rochester, MN.
  • van Gastel EJ; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
  • Armand M; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Tausch E; Strategic Research Program on CLL, B-Cell Neoplasia Unit, Division of Experimental Oncology, Università Vita-Salute San Raffaele/Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
  • Biderman B; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center (UMC), Rotterdam, The Netherlands.
  • Baer C; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Department of Biological Hematology, Sorbonne Université, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.
  • Bagnara D; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Navarro A; National Research Center for Hematology, Moscow, Russia.
  • Langlois de Septenville A; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Guido V; Department of Experimental Medicine, University of Genoa, Genoa, Italy.
  • Mitterbauer-Hohendanner G; Centro de Investigacion Biomedica en Red en Oncologia (CIBERONC), Madrid, Spain.
  • Dimovski A; Institut d'Investigacions Biomediques August Pi I Sunyer, Barcelona, Spain.
  • Brieghel C; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Department of Biological Hematology, Sorbonne Université, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.
  • Lawless S; Molecular Pathology Unit, Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
  • Meggendorfer M; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Brazdilova K; Faculty of Pharmacy, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Northern Macedonia.
  • Ritgen M; Deparment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Facco M; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom.
  • Tresoldi C; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Visentin A; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic.
  • Patriarca A; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Catherwood M; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Bonello L; Hematology and Clinical Immunology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Sudarikov A; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Vanura K; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Roumelioti M; Hematology and Clinical Immunology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  • Skuhrova Francova H; Veneto Institute of Molecular Medicine, Padua, Italy.
  • Moysiadis T; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont-Ospedale Maggiore della Carità, Novara, Italy.
  • Veronese S; Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom.
  • Giannopoulos K; General Anatomopathology and Molecular Oncogenetics, Azienda Ospedaliero Universitaria (AOU), City of Health and Science of Turin, Turin, Italy.
  • Mansouri L; National Research Center for Hematology, Moscow, Russia.
  • Karan-Djurasevic T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Sandaltzopoulos R; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
  • Bödör C; Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University-University Hospital Brno, Brno, Czech Republic.
  • Fais F; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Kater AP; Molecular Pathology Unit, Haematology Department, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
Blood ; 137(10): 1365-1376, 2021 03 11.
Article em En | MEDLINE | ID: mdl-32992344
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Região Variável de Imunoglobulina / Leucemia Linfocítica Crônica de Células B / Cadeias Pesadas de Imunoglobulinas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Região Variável de Imunoglobulina / Leucemia Linfocítica Crônica de Células B / Cadeias Pesadas de Imunoglobulinas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia